Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update

Go back to Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update
Labranche & Co (NASDAQ: LAB) Delayed: 0.61 -0.03 (4.69%)
Previous Close $0.64    52 Week High $4.47 
Open $0.63    52 Week Low $3.02 
Day High $0.65    P/E N/A 
Day Low $0.60    EPS $-1.56 
Volume 322,544